(Q40099412)

17 September 2017

title

Epstein-Barr herpesvirus infection: Inhibition by immunologically induced mediators with interferon-like properties (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

29 December 2022

main subject

Epstein–Barr virus

0 references

lymphocyte activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198380

29 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

29 December 2022

author name string

P. K. Lai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198380

29 December 2022

M. P. Alpers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198380

29 December 2022

E. M. MacKay-Scollay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198380

29 December 2022

language of work or name

English

0 references

publication date

1 July 1977

1 reference

17 September 2017

15 July 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=198380

full work available at URL

29 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910200106

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910200106

29 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

International Journal of Cancer

29 December 2022

published in

1 reference

17 September 2017

volume

20

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

21-29

1 reference

Persistence of the Viral Genome in Interferon-Treated Cells Infected with Oncogenic or Nononcogenic Viruses

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910200106

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910200106

Influence of exogenous interferon on the peripheral white blood cell count in mice

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

In vitro cellular immunity to Epstein-Barr virus in normal human subjects

29 December 2022

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Association of EB-virus infection with the post-perfusion syndrome

29 December 2022

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

29 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations

29 December 2022

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

29 December 2022

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

29 December 2022

Interferon

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response

29 December 2022

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

In Vitro Evaluation of Cell-Mediated Immunity to Epstein-Barr Herpesvirus by Cell Migration Inhibition Tests2

29 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Synthesis of virus-capsid antigen (VCA) enhanced by ultraviolet irradiation of a lymphoblastoid cell line carrying Epstein-Barr virus

29 December 2022

19

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Epidemiological studies of Epstein–Barr herpesvirus infection in Western Australia

29 December 2022

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis

29 December 2022

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody.

29 December 2022

25

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Annals of clinical research

29 December 2022

26

8

151

Nielsson

1976

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

29 December 2022

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Identification of the filtrable leukocyte-transforming factor of qimr-wil cells as herpes-like virus

29 December 2022

28

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis

29 December 2022

29

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3

29 December 2022

31

1 reference

https://api.crossref.org/works/10.1002/IJC.2910200106

29 December 2022

Identifiers

1 reference

17 September 2017

1 reference